![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 39, 30740-30745, September 29, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Neurofibromatosis type 1 (NF1) is a common
genetic disorder characterized by multiple neurofibromas, peripheral
nerve tumors containing mainly Schwann cells and fibroblasts. The
NF1 gene encodes neurofibromin, a tumor suppressor
postulated to function in part as a Ras GTPase-activating
protein. The roles of different cell types and of elevated
Ras-GTP in neurofibroma formation are unclear. To determine which
neurofibroma cell type has altered Ras-GTP regulation, we developed an
immunocytochemical assay for active, GTP-bound Ras. In NIH 3T3 cells,
the assay detected overexpressed, constitutively activated K-, N-, and
Ha-Ras and insulin-induced endogenous Ras-GTP. In dissociated
neurofibroma cells from NF1 patients, Ras-GTP was elevated in Schwann
cells but not fibroblasts. Twelve to 62% of tumor Schwann cells showed
elevated Ras-GTP, unexpectedly revealing neurofibroma Schwann cell
heterogeneity. Increased basal Ras-GTP did not correlate with increased
cell proliferation. Normal human Schwann cells, however, did not
demonstrate elevated basal Ras activity. Furthermore, compared with
cells from wild type littermates, Ras-GTP was elevated in all mouse Nf1
Single Cell Ras-GTP Analysis Reveals Altered Ras Activity in a
Subpopulation of Neurofibroma Schwann Cells but Not Fibroblasts*
§,
,
**, and

Department of Cell Biology, Neurobiology and
Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio
45267-0521, the ¶ Department of Neuropediatrics, Children's
Hospital, Heinrich-Heine-University, Dusseldorf, Germany, and the
Departments of Radiation Oncology and Pharmacology, University
of North Carolina, Chapel Hill, North Carolina 27599-7512
/
Schwann cells but never in
Nf1
/
mouse fibroblasts. Our results
indicate that Ras activity is detectably increased in only some
neurofibroma Schwann cells and suggest that neurofibromin is not an
essential regulator of Ras activity in fibroblasts.
*
This work was supported by National Institutes of Health
(NIH) Grant NS28840 (to N. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Cell
Biology, Neurobiology, and Anatomy, University of Cincinnati College of
Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521. Tel.: 513-558-6079; Fax: 513-558-4454; E-mail: Nancy.Ratner@uc.edu.
This article has been cited by other articles:
![]() |
F. Farassati, W. Pan, F. Yamoutpour, S. Henke, M. Piedra, S. Frahm, S. Al-Tawil, W. I. Mangrum, L. F. Parada, S. D. Rabkin, et al. Ras Signaling Influences Permissiveness of Malignant Peripheral Nerve Sheath Tumor Cells to Oncolytic Herpes Am. J. Pathol., December 1, 2008; 173(6): 1861 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sandsmark, H. Zhang, B. Hegedus, C. L. Pelletier, J. D. Weber, and D. H. Gutmann Nucleophosmin Mediates Mammalian Target of Rapamycin-Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes Cancer Res., May 15, 2007; 67(10): 4790 - 4799. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lavery, V. Hall, J. C. Yager, A. Rottgers, M. C. Wells, and M. Stern Phosphatidylinositol 3-Kinase and Akt Nonautonomously Promote Perineurial Glial Growth in Drosophila Peripheral Nerves J. Neurosci., January 10, 2007; 27(2): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Barkan, S. Starinsky, E. Friedman, R. Stein, and Y. Kloog The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1. Clin. Cancer Res., September 15, 2006; 12(18): 5533 - 5542. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Yang, S. Chen, T. Clegg, X. Li, T. Morgan, S. A. Estwick, J. Yuan, W. Khalaf, S. Burgin, J. Travers, et al. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-{beta} signaling Hum. Mol. Genet., August 15, 2006; 15(16): 2421 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, G. D. Nicol, D. W. Clapp, and C. M. Hingtgen Sensory Neurons From Nf1 Haploinsufficient Mice Exhibit Increased Excitability J Neurophysiol, December 1, 2005; 94(6): 3670 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dasgupta, Y. Yi, B. Hegedus, J. D. Weber, and D. H. Gutmann Cerebrospinal Fluid Proteomic Analysis Reveals Dysregulation of Methionine Aminopeptidase-2 Expression in Human and Mouse Neurofibromatosis 1-Associated Glioma Cancer Res., November 1, 2005; 65(21): 9843 - 9850. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dasgupta, Y. Yi, D. Y. Chen, J. D. Weber, and D. H. Gutmann Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1-Associated Human and Mouse Brain Tumors Cancer Res., April 1, 2005; 65(7): 2755 - 2760. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dasgupta, W. Li, A. Perry, and D. H. Gutmann Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes Cancer Res., January 1, 2005; 65(1): 236 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Corfas, M. O. Velardez, C.-P. Ko, N. Ratner, and E. Peles Mechanisms and Roles of Axon-Schwann Cell Interactions J. Neurosci., October 20, 2004; 24(42): 9250 - 9260. [Full Text] [PDF] |
||||
![]() |
R. L. Berdeaux, B. Diaz, L. Kim, and G. S. Martin Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function J. Cell Biol., August 2, 2004; 166(3): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
K S G Cunha, E P Barboza, and E C Da Fonseca Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1 J. Clin. Pathol., October 1, 2003; 56(10): 758 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bennett, T. A. Rizvi, S. Karyala, R. D. McKinnon, and N. Ratner Aberrant Growth and Differentiation of Oligodendrocyte Progenitors in Neurofibromatosis Type 1 Mutants J. Neurosci., August 6, 2003; 23(18): 7207 - 7217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Miller, H. Li, T. A. Rizvi, Y. Huang, G. Johansson, J. Bowersock, A. Sidani, J. Vitullo, K. Vogel, L. M. Parysek, et al. Brain Lipid Binding Protein in Axon-Schwann Cell Interactions and Peripheral Nerve Tumorigenesis Mol. Cell. Biol., March 15, 2003; 23(6): 2213 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kemkemer, S. Schrank, W. Vogel, H. Gruler, and D. Kaufmann Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro PNAS, October 15, 2002; 99(21): 13783 - 13788. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Korf Review Article : Clinical Features and Pathobiology of Neurofibromatosis 1 J Child Neurol, August 1, 2002; 17(8): 573 - 577. [Abstract] [PDF] |
||||
![]() |
H. Li, S. Velasco-Miguel, W. C. Vass, L. F. Parada, and J. E. DeClue Epidermal Growth Factor Receptor Signaling Pathways Are Associated with Tumorigenesis in the Nf1:p53 Mouse Tumor Model Cancer Res., August 1, 2002; 62(15): 4507 - 4513. [Abstract] [Full Text] [PDF] |
||||
![]() |
Plexiform neurofibromas in NF1: Toward biologic-based therapy Neurology, May 28, 2002; 58(10): 1461 - 1470. |
||||
![]() |
R. E. Ferner and D. H. Gutmann International Consensus Statement on Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis 1 Cancer Res., March 1, 2002; 62(5): 1573 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yager, S. Richards, D. S. Hekmat-Scafe, D. D. Hurd, V. Sundaresan, D. R. Caprette, W. M. Saxton, J. R. Carlson, and M. Stern Control of Drosophila perineurial glial growth by interacting neurotransmitter-mediated signaling pathways PNAS, August 17, 2001; (2001) 191107698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Gutmann The neurofibromatoses: when less is more Hum. Mol. Genet., April 1, 2001; 10(7): 747 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Serra, T. Rosenbaum, U. Winner, R. Aledo, E. Ars, X. Estivill, H.-G. Lenard, and C. Lazaro Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations Hum. Mol. Genet., December 1, 2000; 9(20): 3055 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yager, S. Richards, D. S. Hekmat-Scafe, D. D. Hurd, V. Sundaresan, D. R. Caprette, W. M. Saxton, J. R. Carlson, and M. Stern Control of Drosophila perineurial glial growth by interacting neurotransmitter-mediated signaling pathways PNAS, August 28, 2001; 98(18): 10445 - 10450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |